Comparative Pharmacology
Head-to-head clinical analysis: INTRALIPID 10 versus INTRALIPID 30.
Peer-Reviewed Evidence
Head-to-head clinical analysis: INTRALIPID 10 versus INTRALIPID 30.
INTRALIPID 10% vs INTRALIPID 30%
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Intralipid 10% is a fat emulsion that provides essential fatty acids (linoleic and linolenic acids) and a source of energy. It acts as a carrier for fat-soluble vitamins and prevents essential fatty acid deficiency. The mechanism involves direct utilization of triglycerides for energy after hydrolysis by lipoprotein lipase.
Intralipid is a source of calories and essential fatty acids. It provides a mixture of triglycerides, primarily long-chain fatty acids, which are metabolized to generate energy and serve as substrates for lipid membrane synthesis. It also prevents essential fatty acid deficiency.
Intravenous infusion. Adult: 500 mL of 10% emulsion (50 g fat) over 4-6 hours, up to 2.5 g fat/kg/day. Maximum infusion rate: 0.1 g fat/kg/hour.
Intralipid 30% is administered intravenously as a component of parenteral nutrition. The typical adult dose is 1-2 g/kg/day of fat, not to exceed 60% of total calories. The infusion rate should not exceed 0.11 g/kg/hour (equivalent to 0.37 mL/kg/hour of 30% emulsion).
None Documented
None Documented
The terminal elimination half-life of Intralipid triglycerides is approximately 30-60 minutes in adults with normal lipid metabolism. In neonates and patients with impaired clearance, half-life may be prolonged to 2-4 hours. Clinical context: half-life increases with infusion rate; at steady state, clearance is rapid due to extrahepatic lipolysis.
The elimination half-life of Intralipid 30% triglycerides is approximately 30-45 minutes under steady-state conditions in patients with normal lipid metabolism, though this may extend to several hours in critically ill patients or those with impaired clearance. Clinically, the half-life is dose- and infusion-rate-dependent; for continuous infusion, clearance rates are typically 0.1-0.3 g/kg/h, with complete clearance of infused lipids within 4-6 hours after cessation of infusion in healthy adults.
Intralipid 10% (IV fat emulsion) is metabolized like endogenous chylomicrons; elimination is not via renal or biliary routes. Triglycerides are hydrolyzed by lipoprotein lipase, and the resulting free fatty acids are taken up by tissues. Less than 0.5% is excreted unchanged in urine. Biliary excretion of metabolites is negligible.
Intralipid 30% is a fat emulsion containing soybean oil, egg lecithin, and glycerin, providing essential fatty acids and triglycerides. The lipid particles are metabolized similarly to endogenous chylomicrons, primarily cleared from the bloodstream by lipoprotein lipase in peripheral tissues, releasing free fatty acids which are then utilized or stored. Less than 10% of the administered dose is excreted unchanged in urine; the majority of the lipid components are oxidized to CO2 and water or incorporated into body stores. Biliary/fecal excretion is negligible for the intact emulsion but metabolites may be excreted in bile or feces in small amounts.
Category C
Category C
Intravenous Fat Emulsion
Intravenous Fat Emulsion